DIA 4th Annual Clinical Forum & Exhibition

11-13 October 2010, Lisbon, Portugal

The DIA 4th Annual Clinical Forum provides access to sessions covering nine multidisciplinary themes, including Clinical Data Management/eClinical, Clinical Operations, Clinical Research, Peri- and Post Approval Studies, Drug Safety and Risk Management, Quality Assurance, Clinical Endpoints, e-Technology and Validation and Medical Information & Communications.
More info >>

Glycotope GMBH

Berlin, Germany – August 4, 2010 Glycotope GmbH, a leading glycobiology company, has received regulatory approval by German and Italian regulatory authorities for a Phase I study of Glycotope´s next generation antibody CetuGEX (GT-MAB 5.2-GEX) for the treatment of various solid cancers.
More info >>